
According to a LifeSiteNews.com news report - The British
Medical Journal (BMJ) has
reported that a healthy 16-year-old Australian girl
lost all ovarian function and went into menopause after being injected with the
human papilloma virus (HPV) vaccine Gardasil.
We have on numerous occasions referred to the
problems
associated with the Gardasil vaccination programme because of the injuries,
illnesses and deaths that
have
been found to be associated with it.
We reported in 2011 that since its introduction,
nearly 100 deaths had taken place at that time, and nearly 22,000 adverse
reactions had been recorded worldwide.
In Ireland alone, hundreds of adverse reactions have
been reported to the authorities – which have ignored this information.
Two ingredients of Gardasil – sodium borate (pesticide) and
Polysorbate 80 – are linked to infertility. As well as that, the link between Gardasil and the huge
increase in stillbirths and the early death of children in the womb is already
well documented.
Dr. Deirdre Little, the Australian physician who treated the
girl, provides solid evidence that Gardasil caused the destruction of the
girl's fertility.
She also pointed out that Merck Pharmaceutical, the
manufacturer of Gardasil, has no supporting information on the effects of the
vaccine on ovaries, suggesting that Merck had either done no safety testing on
Gardasil in relation to its effects on women's reproductive systems, or had
suppressed the information.
Dr. Little's report states that before the Gardasil
vaccination, the girl had regular menstrual cycles, had been thoroughly
examined and tested, and had no family or personal medical history that could
explain the premature menopause.
The girl received the Gardasil vaccination in the fall of
2008. By January 2009, her cycle had become irregular. Over the course of the
next two years, her menses became increasingly scant and irregular, until by
2011, she had ceased menstruating altogether.
"This patient presented with amenorrhoea after
identifying a change from her regular cycle to irregular and scant periods
following vaccinations against human papillomavirus," Dr. Little wrote in
the report.
Dr. Little carried out numerous tests on the girl, including
checking hormone levels and internal organ function, and diagnosed her as
having "premature ovarian failure." She also found that the girl had
no living egg cells.
After investigating other possible causes of the girl's
premature ovarian failure, Dr. Little was left with the Gardasil vaccination as
the only remaining explanation.
"Although the cause is unknown in 90% of cases, the
remaining chief identifiable causes of this condition were excluded. Premature
ovarian failure was then notified as a possible adverse event following this
vaccination," Dr. Little stated.
In the report titled "Premature ovarian failure 3 years
after menarche in a 16-year-old girl following human papillomavirus
vaccination," Little wrote that Merck had only tested Gardasil's effects
on the testes of rats.
Dr. Little contacted the Therapeutic Goods Administration
(TGA) of Australia, the equivalent of the U.S. Food and Drug Administration
(FDA), for information about the safety testing of Gardasil on women's ovaries.
She found that the TGA had records of various tests on rat
testes, but no records of the effect of the vaccine on rat ovaries in the
Australian Public Assessment Report for Human Papillomavirus Quadrivalent
Vaccine (Gardasil).
Dr. Little's report states that, "It is not known
whether this event of premature ovarian failure is linked to the quadrivalent
HPV vaccine. More detailed information concerning rat ovarian histology and
ongoing fecundity post-HPV vaccination was sought from the Therapeutic Goods
Administration (TGA).”
It revealed that “no histological report has been available
for vaccinated rat ovaries."
In other words, the TGA had no safety information on the
effect of Gardasil on female reproductive systems.
"This event could hold potential implications for
population health and prompts further inquiry," Dr. Little's report
concluded.
"Gardasil has been controversial from the
beginning," noted Steven Mosher of the Population Research Institute.
"While other vaccines protect against diseases spread
by casual contact, Gardasil was developed to protect against a sexually
transmitted disease," Mosher said, adding that Merck Pharmaceutical has
proven effective in lobbying governments around the world to make the vaccine
mandatory for schoolchildren.
"Tens of millions of young girls have received the
Gardasil vaccine since its approval by the FDA six years ago. If even a tiny
fraction of them have experienced infertility as a result, then these girl
children have been denied a very fundamental right, that is, the right to
decide how many children they want to have," Mosher said.
"In the case of the Australian girl the effect is
irreversible. She has lost an integral part of her womanhood, while still but a
child,” he said. “Women deserve better."